The Programming Document 2020-22 translates the long-term priorities defined by the EMCDDA Strategy 2025 into short-term operational priorities
Bibliography: International Policy Issues
Monitoring and evaluating changes in cannabis policies: insights from the Americas
This report provides an overview of the changes in cannabis policies in the Americas and the evidence emerging from evaluations of their impact (EMCDDA)
EU Drug Markets Report 2019
EMCDDA Director presents EU Drug Markets Report 2019 at European Parliament — ‘a clear wake-up call for policymakers’
EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances
These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System (EMCDDA)
UN Common Position on drug policy – Consolidating system-wide coherence
This briefing paper reconstructs the long and troubled process that led to the adoption of this ground-breaking UN System Common Position (TNI)
Terrorism and drugs in Europe
Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between 2012 and 2017 (EMCDDA)
Using open-source information to improve the European drug monitoring system
This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in 2016, the technique has recently been expanded to cover open-source information through a pilot project focusing on data on heroin and cocaine seizures of 100 kg or more for the European market between April 2017 and March 2018 (EMCDDA)
Drug precursor developments in the European Union
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU (EMCDDA)
Methamphetamine in Europe: EMCDDA-Europol threat assessment
This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution (EMCDDA)
EU Drug Markets Report 2019
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol.
Position of the European Society for Prevention Research on ineffective and potentially harmful approaches in substance use prevention
Prevention methods using shock tactics are proven to be ineffective. Nevertheless, strategies based on predominantly providing information about the dangers of substance use are widespread in Europe (European Society for Prevention Research)
The Reitox network: frequently asked questions
This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories (EMCDDA)
HIV and people who inject drugs (PDF)
Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report (ecdc)
Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016 (EMCDDA)
Healthy, prosperous lives for all: the European Health Equity Status Report (PDF)
This report identifies five essential conditions needed to create and sustain a healthy life for all: good quality and accessible health services; income security and social protection; decent living conditions; social and human capital and decent work and employment conditions. Policy actions are needed to address all five conditions (WHO)
Frequently asked questions (FAQ): drug overdose deaths in Europe
This page provides an update on drug-related deaths in Europe, presenting and analysing the latest data on and trends in drug-induced deaths in the European Union, Norway and Turkey. It draws on contributions from specialists from these countries, as well as on information provided by European countries in the annual reporting exercise to the agency (EMCDDA)
Latest update on drug-related deaths and mortality in Europe
The information provided in the report is collected through the EMCDDA’s expert network on drug-related deaths (DRD)
Serbia — Early warning system profile
The profile presents the structure, objectives and working methods of the Serbian national early warning system (EMCDDA)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
World Drug Report 2019
Presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history (UNODC)
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 12
- Next Page »
